Does TUCIDINOSTAT Cause Myelosuppression? 85 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 85 reports of Myelosuppression have been filed in association with TUCIDINOSTAT. This represents 33.9% of all adverse event reports for TUCIDINOSTAT.
85
Reports of Myelosuppression with TUCIDINOSTAT
33.9%
of all TUCIDINOSTAT reports
4
Deaths
24
Hospitalizations
How Dangerous Is Myelosuppression From TUCIDINOSTAT?
Of the 85 reports, 4 (4.7%) resulted in death, 24 (28.2%) required hospitalization, and 19 (22.4%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TUCIDINOSTAT. However, 85 reports have been filed with the FAERS database.
What Other Side Effects Does TUCIDINOSTAT Cause?
Disease progression (37)
Anaemia (33)
Pneumonia (30)
Off label use (28)
Platelet count decreased (24)
Nausea (22)
White blood cell count decreased (21)
Drug ineffective (19)
Treatment failure (16)
Neutrophil count decreased (15)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which TUCIDINOSTAT Alternatives Have Lower Myelosuppression Risk?
TUCIDINOSTAT vs TYKERB
TUCIDINOSTAT vs TYLENOL
TUCIDINOSTAT vs TYROTHRICIN
TUCIDINOSTAT vs TYSABRI
TUCIDINOSTAT vs TYVASO